Please provide your email address to receive an email when new articles are posted on . Direct-to-consumer testing, combined with clinical follow-up, helped identify patients with undiagnosed alpha-1 ...
Hosted on MSN
Alpha-1 antitrypsin deficiency: Study reveals why some patients with the hereditary disease remain healthy
Alpha-1-antitrypsin is a so-called protease inhibitor, a type of enzyme inhibitor. It is produced in the liver but exerts its effects in the lungs, where it regulates immune cell activity. This ...
Alpha-1 antitrypsin (AAT) deficiency is a genetic disease where your body doesn’t make enough normal functioning AAT. AAT is a protein your liver makes. AAT has many important roles in your body, ...
The presentation will introduce the Company’s novel SyNTase gene editing technology and highlight its application in ...
PHILADELPHIA (WPVI) -- About 11 years ago, Ron MacGuire Jr. suffered a terrible fall while at work. "I fell seven stories and survived," he said admitting that he is still stunned he wasn't killed.
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Augmentation therapy increased survival in patients with ...
New research shows that people diagnosed with a genetic condition, called alpha-1 antitrypsin deficiency (AATD), are far more likely to stop smoking and therefore prevent the development of lung ...
The "Global Alpha-1 Antitrypsin Drugs Market 2018-2022" report has been added to ResearchAndMarkets.com's offering. The Global Alpha-1 Antitrypsin Drugs Market to grow at a CAGR of 10.64% during the ...
Alpha-1 antitrypsin deficiency (AATD) is a hereditary condition characterised by the misfolding of the alpha-1 antitrypsin (AAT) protein, resulting in its hepatic accumulation and compromised protease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback